EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of EGR1/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma

Jingxian Luo, Mingqiang Su, Xianyong Li, Dayong Ye, Xiaofu Zeng, Yujie Wang, Guangqing Fu iD

Briefings in Functional Genomics · 2026

DOI: 10.1093/bfgp/elaf023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Functional Genomics, 2026. Verfasst von Jingxian Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zigong Fourth People's Hospital, No. 19, Tanmulin Street, Ziliujing District, Zigong, 643000, Sichuan, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Early Growth Response Protein 1, Cuproptosis, Kidney Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) is one of the most prevalent solid tumors, and chromophobe renal cell carcinoma (chRCC) is its third most common subtype. The cuproptosis has become a hot topic in the field of cancer treatment. This study aimed to investigate the potential targets of cuproptosis in chRCC cells. We first downloaded the chRCC mRNA transcriptome data from The Cancer Genome Atlas. Based on the previous reports, we speculated that the expression of LIPT1 was considerably down-regulated in chRCC tissues. The upstream transcription factor (TF) EGR1 was predicted by the hTFtarget web tool, and the interaction between EGR1 and LIPT1 was further verified by dual-luciferase and chromatin immunoprecipitation experiments. The mRNA expression levels of EGR1 and LIPT1 were detected by quantitative polymerase chain reaction. The expression levels of target protein LIPT1 and cuproptosis-associated protein were detected by western blot and immunofluorescence. Cell Counting Kit-8 assay was employed to detect the viability of RCC98 cells. The Transwell assay was utilized to assess the migration and invasion abilities of RCC98 cells. LIPT1 and its upstream TF, EGR1, were significantly down-regulated in chRCC tissues and cells. EGR1 could transcriptionally activate LIPT1. Additionally, overexpression of LIPT1 significantly reduced the cancer-associated malignant phenotype of chRCC and elevated the sensitivity of RCC98 cells to cuproptosis. However, on this basis, knocking down EGR1 restored the anti-cancer effect conferred by overexpression of LIPT1. This work aimed to investigate the transcriptional activation of LIPT1 by EGR1 in RCC98 cells to repress the malignant progression of cancer cells while enhancing the sensitivity of RCC98 cells to cuproptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellEarly Growth Response Protein 1CuproptosisKidney NeoplasmsHumansGene Expression Regulation, NeoplasticCell Line, TumorCell Movement

Stichwörter der Autor:innen

EGR1LIPT1chromophobe renal cell carcinomacuproptosismalignancy progression

Substanzen

Early Growth Response Protein 1EGR1 protein, human

Autor:innen und Institutionen

  • Department of Urology, Zigong Fourth People's Hospital, No. 19, Tanmulin Street, Ziliujing District, Zigong, 643000, Sichuan, China.

ORCID-Profile: Guangqing Fu

Zitieren

APA

Luo, J., Su, M., Li, X., Ye, D., Zeng, X., Wang, Y., & Fu, G. (2026). Effect of EGR1/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma. Briefings in Functional Genomics. https://doi.org/10.1093/bfgp/elaf023

Vancouver

Luo J, Su M, Li X, Ye D, Zeng X, Wang Y, et al. Effect of EGR1/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma. Briefings in Functional Genomics. 2026. doi:10.1093/bfgp/elaf023

BibTeX
@article{Luo2026,
  author = {Luo, Jingxian and Su, Mingqiang and Li, Xianyong and Ye, Dayong and Zeng, Xiaofu and Wang, Yujie and Fu, Guangqing},
  title = {Effect of EGR1/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma},
  journal = {Briefings in Functional Genomics},
  year = {2026},
  doi = {10.1093/bfgp/elaf023}
}
Kostenlos starten →